PuSH - Publication Server of Helmholtz Zentrum München

Budde, K.* ; Lange, C.* ; Reimann, M.* ; Zielinski, N.* ; Meiwes, L.* ; Köhler, N.* ; DZIF TB cohort study group (Hoelscher, M.)

A novel method for detecting Lipoarabinomannan in urine with the promise of meeting the WHO target product profile for the diagnosis of tuberculosis.

Tuberculosis 152:40048961 (2025)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
The diagnosis of tuberculosis largely relies on the detection of Mycobacterium tuberculosis (M. tuberculosis) via pathogen-specific DNA or bacterial culture from sputum samples. As the only point-of-care test so far, urinary lipoarabinomannan (LAM) has been endorsed by the World Health Organization for the diagnosis of tuberculosis in people living with HIV. In this study, the electrochemiluminescence LAM research assay (EclLAM) was used to measure LAM in the urine of HIV-sero-negative individuals with pulmonary tuberculosis and to monitor anti-tuberculosis treatment. Urine samples from 18 patients with microbiologically confirmed tuberculosis were analyzed before and after the initiation of anti-tuberculosis therapy and 17 healthy controls via the S4-20/A194-01 antibody pair. The assay identified 13/18 (72.2 %) patients with tuberculosis and was negative in 17/17 (100.0 %) controls (AUC 0.88). The results of the reactive urine LAM tests correlated with the detection of M. tuberculosis growth in culture (r = 0.94, p < 0.05). In conclusion, the LAM-specific antibody assay is promising to fulfill the WHO target product profile for the diagnosis of tuberculosis.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Biomarker ; Diagnostic Tests ; Enzyme-linked Immunosorbent Assay ; Lipoarabinomannan ; Mycobacterium Tuberculosis ; Pulmonary Tuberculosis
ISSN (print) / ISBN 1472-9792
e-ISSN 1873-281X
Journal Tuberculosis
Quellenangaben Volume: 152, Issue: , Pages: , Article Number: 40048961 Supplement: ,
Publisher Elsevier
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Research Unit Global Health (UGH)